focus -WSS

focus

author：fashion 2025-10-01 15:39:38 - browse：553

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

focus

hotspot

WSS

A new nitrogen execution bill also undermines medical licensing

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Death of patient in Alzheimer’s trial raises question of possible risks

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Colonoscopy at 40? Study finds a possible benefit

Alabama hospital puts IVF treatments on hold

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

How to save PrEP access — and even expand it

STAT readers on older presidents, polypills, Medicare, and more

Medical leaders decry Supreme Court decision on affirmative action

The story of mRNA: From a loose idea to a tool that may help curb Covid

ChatGPT in medicine: STAT answers readers' burning questions

Weight bias in eating disorder treatment complicated by new weight loss drugs

Duchenne breakthrough therapy leaves behind pioneering families

Gene therapy has helped boys walk. Can scientists keep it that way?

Continuity nursing helped my family in our darkest PICU moments

The story of mRNA: From a loose idea to a tool that may help curb Covid

entertainment

STAT readers on older presidents, polypills, Medicare, and more

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

WATCH: Why do fingernails fall off when they're damaged?

focus

hotspot

leisure time

hotspot